Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
128.09
0.13 (0.10%)
At close: Jun 16, 2025, 3:59 PM
128.16
0.05%
After-hours: Jun 16, 2025, 06:22 PM EDT
Blueprint Medicines Revenue
Blueprint Medicines reported an annual revenue of $508.82M, reflecting a 104.04% growth. For the quarter ending March 31, 2025, Blueprint Medicines generated $149.41M in revenue.
Revenue (ttm)
$508.82M
Revenue Growth
104.04%
Price / Sales Ratio
10.77
Revenue / Employee
$746.08K
Employees
682
Market Cap
8.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|